📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A Novel Radiogenomics Biomarker for Predicting Treatment Response and Pneumotoxicity From Programmed Cell Death Protein or Ligand-1 Inhibition Immunotherapy in NSCLC. (2023)

First Author: Chen M

Attributed to: Development of Metabolism Radiotracers to Probe Disease Pathology in Human Subjects with Cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jtho.2023.01.089

PubMed Identifier: 36773776

Publication URI: http://europepmc.org/abstract/MED/36773776

Type: Journal Article/Review

Volume: 18

Parent Publication: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Issue: 6

ISSN: 1556-0864